Cheap diabetes drug reduces risk of long COVID: study
People who took a cheap diabetes drug after testing positive for COVID-19 had a 40 percent lower risk of getting long COVID, a US-based study said Friday.
Jun 11, 2023
0
42
People who took a cheap diabetes drug after testing positive for COVID-19 had a 40 percent lower risk of getting long COVID, a US-based study said Friday.
Jun 11, 2023
0
42
Taking a two-week course of metformin, a safe and affordable diabetes medication after testing positive for SARS-CoV-2 leads to 40% fewer long COVID diagnoses over the following 10 months, compared to individuals taking a ...
Jun 8, 2023
0
251
University of Arizona Health Sciences researchers are taking the foot off the brake in their quest to improve opioid therapy while decreasing its side effects.
May 15, 2023
0
60
For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.
Mar 21, 2023
0
0
A recent UNC-Chapel Hill School of Medicine study has concluded that metformin—a drug used to control high blood sugar—along with insulin did not reduce risks for adverse neonatal outcomes compared with a placebo along ...
Mar 21, 2023
0
24
A recent Mayo Clinic study published in the Journal of Clinical Endocrinology & Metabolism has found that using machine learning and electronic health record (EHR) data can help pinpoint patients with type 2 diabetes who ...
Feb 10, 2023
0
36
Is an ancient compound the new "wonder drug"?
Jan 5, 2023
0
68
Osteoarthritis is a common chronic condition that usually causes joint pain and can be severe enough to require knee and hip replacements. In the United States, the number of total knee replacement (TKR) and total hip replacement ...
Dec 19, 2022
0
32
Metformin, the most prescribed drug for treating diabetes mellitus, known as type 2 diabetes, requires the presence of the growth differentiation factor 15 (GDF15)—a protein whose expression increases in response to cellular ...
Dec 16, 2022
0
24
A new research paper titled "The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study" has been published in Aging.
Dec 7, 2022
0
13